Sturgeon C, Wagenblast E, Izzo F, Papapetrou E
Blood Cancer Discov. 2024; 6(2):94-109.
PMID: 39652739
PMC: 11876951.
DOI: 10.1158/2643-3230.BCD-24-0235.
Bacharach T, Shlush L
Haematologica. 2023; 108(12):3191-3192.
PMID: 38037797
PMC: 10690888.
DOI: 10.3324/haematol.2023.284215.
Lauber C, Correia N, Trumpp A, Rieger M, Dolnik A, Bullinger L
Sci Rep. 2020; 10(1):12761.
PMID: 32728112
PMC: 7391693.
DOI: 10.1038/s41598-020-69691-8.
Park S, Bejar R
Curr Stem Cell Rep. 2019; 4(3):209-219.
PMID: 30854305
PMC: 6402340.
DOI: 10.1007/s40778-018-0133-9.
Chae H, Cox N, Dahl G, Lacayo N, Davis K, Capolicchio S
Oncotarget. 2018; 9(4):4301-4317.
PMID: 29435104
PMC: 5796975.
DOI: 10.18632/oncotarget.23794.
Preleukemic Hematopoietic Stem Cells in Human Acute Myeloid Leukemia.
Corces M, Chang H, Majeti R
Front Oncol. 2017; 7:263.
PMID: 29164062
PMC: 5681525.
DOI: 10.3389/fonc.2017.00263.
Dysregulation of haematopoietic stem cell regulatory programs in acute myeloid leukaemia.
Basilico S, Gottgens B
J Mol Med (Berl). 2017; 95(7):719-727.
PMID: 28429049
PMC: 5487585.
DOI: 10.1007/s00109-017-1535-3.
Clonal hematopoiesis.
Jan M, Ebert B, Jaiswal S
Semin Hematol. 2017; 54(1):43-50.
PMID: 28088988
PMC: 8045769.
DOI: 10.1053/j.seminhematol.2016.10.002.
Preleukemia: one name, many meanings.
Koeffler H, Leong G
Leukemia. 2016; 31(3):534-542.
PMID: 27899806
PMC: 5339433.
DOI: 10.1038/leu.2016.364.
Unravelling the relevance of CLEC12A as a cancer stem cell marker in myelodysplastic syndrome.
Toft-Petersen M, Nederby L, Kjeldsen E, Kerndrup G, Brown G, Hokland P
Br J Haematol. 2016; 175(3):393-401.
PMID: 27612176
PMC: 5091626.
DOI: 10.1111/bjh.14270.
A novel PAD4/SOX4/PU.1 signaling pathway is involved in the committed differentiation of acute promyelocytic leukemia cells into granulocytic cells.
Song G, Shi L, Guo Y, Yu L, Wang L, Zhang X
Oncotarget. 2015; 7(3):3144-57.
PMID: 26673819
PMC: 4823096.
DOI: 10.18632/oncotarget.6551.
Rapid expansion of preexisting nonleukemic hematopoietic clones frequently follows induction therapy for de novo AML.
Wong T, Miller C, Klco J, Petti A, Demeter R, Helton N
Blood. 2015; 127(7):893-7.
PMID: 26631115
PMC: 4760092.
DOI: 10.1182/blood-2015-10-677021.
Aging, clonal hematopoiesis and preleukemia: not just bad luck?.
Shlush L, Zandi S, Itzkovitz S, Schuh A
Int J Hematol. 2015; 102(5):513-22.
PMID: 26440972
DOI: 10.1007/s12185-015-1870-5.
Pre-leukemic evolution of hematopoietic stem cells: the importance of early mutations in leukemogenesis.
Corces-Zimmerman M, Majeti R
Leukemia. 2014; 28(12):2276-82.
PMID: 25005245
PMC: 4262622.
DOI: 10.1038/leu.2014.211.
Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia.
Shlush L, Zandi S, Mitchell A, Chen W, Brandwein J, Gupta V
Nature. 2014; 506(7488):328-33.
PMID: 24522528
PMC: 4991939.
DOI: 10.1038/nature13038.
Concise review: preleukemic stem cells: molecular biology and clinical implications of the precursors to leukemia stem cells.
Pandolfi A, Barreyro L, Steidl U
Stem Cells Transl Med. 2013; 2(2):143-50.
PMID: 23349328
PMC: 3659760.
DOI: 10.5966/sctm.2012-0109.
Sox4 cooperates with CREB in myeloid transformation.
Sandoval S, Kraus C, Cho E, Cho M, Bies J, Manara E
Blood. 2012; 120(1):155-65.
PMID: 22627767
PMC: 3390953.
DOI: 10.1182/blood-2011-05-357418.
Novel agents inhibit human leukemic cells.
Yu W, Li J
Acta Pharmacol Sin. 2012; 33(2):210-1.
PMID: 22231394
PMC: 4010338.
DOI: 10.1038/aps.2011.207.
AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation.
Miyamoto T, Weissman I, Akashi K
Proc Natl Acad Sci U S A. 2000; 97(13):7521-6.
PMID: 10861016
PMC: 16578.
DOI: 10.1073/pnas.97.13.7521.
Genetic heterogeneity in familial acute myelogenous leukemia: evidence for a second locus at chromosome 16q21-23.2.
Horwitz M, Benson K, Li F, Wolff J, Leppert M, Hobson L
Am J Hum Genet. 1997; 61(4):873-81.
PMID: 9382098
PMC: 1716007.
DOI: 10.1086/514894.
